Merck & Co Inc

Swine flu is replacing COVID on pharmaceutical companies’ target list

Analyst ratings changes include AMD, Apple and MongoDB

Obesity, oncology and old age: How 2023 pharmaceutical M&A is reshaping the health-care industry

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

Big Pharma and The Need for Speed

Yumanity Therapeutics To Cut 60% of Staff, Explore Strategic Options